Clinical

Dataset Information

0

Bevacizumab in combination with immune checkpoint inhibitors for the treatment of unresectable or metastatic highly microsatellite unstable or mismatch repair defective colorectal cancer: a multi-center, single-arm exploratory study

ABSTRACT: Interventions: Experimental group:Bevacizumab and Pd-1 monoclonal antibody Primary outcome(s): Progression free survival Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 2715915 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Bevacizumab in combination with immune checkpoint inhibitors for the treatment of unrecectable or metastatic highly microsatelite unstable or mismatch repair defective colorectal cancer: a muti-center, single-arm exploratory clinical study
| 2739485 | ecrin-mdr-crc
Unknown The cost-effectiveness analysis of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair deficient advanced colorectal cancer.
| S-EPMC12738571 | biostudies-literature
Unknown Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency.
| S-EPMC7962453 | biostudies-literature
Unknown DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers.
| S-EPMC6409193 | biostudies-literature
Unknown Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors.
| S-EPMC11749684 | biostudies-literature
Unknown Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status.
| S-EPMC6459114 | biostudies-literature
Unknown Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective Affinities.
| S-EPMC9267485 | biostudies-literature
Unknown Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers.
| S-EPMC9582475 | biostudies-literature
Unknown Immune checkpoint inhibitors for patients with mismatch repair deficient or microsatellite instability-high advanced cancers: a meta-analysis of phase I-III clinical trials.
| S-EPMC11745646 | biostudies-literature
Unknown Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer.
| S-EPMC9726864 | biostudies-literature